CHARLES SCHWAB INVESTMENT MANAGEMENT INC - DESIGN THERAPEUTICS INC ownership

DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 51 filers reported holding DESIGN THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of DESIGN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$409,566
-71.6%
173,545
-24.2%
0.00%
Q2 2023$1,441,478
+8.5%
228,806
-0.7%
0.00%
Q1 2023$1,329,102
-43.9%
230,347
-0.2%
0.00%
-100.0%
Q4 2022$2,369,157
-36.9%
230,912
+2.8%
0.00%0.0%
Q3 2022$3,755,000
+99.0%
224,560
+66.6%
0.00%0.0%
Q2 2022$1,887,000
-4.6%
134,775
+10.1%
0.00%0.0%
Q1 2022$1,977,000
-22.1%
122,368
+3.2%
0.00%0.0%
Q4 2021$2,539,000
+90.9%
118,556
+31.0%
0.00%
Q3 2021$1,330,000
-23.8%
90,521
+3.1%
0.00%
-100.0%
Q2 2021$1,746,00087,7650.00%
Other shareholders
DESIGN THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 5,626,476$78,771,00038.55%
Logos Global Management LP 2,797,501$39,165,0007.18%
Cormorant Asset Management, LP 5,500,000$77,000,0005.82%
Ghost Tree Capital, LLC 275,000$3,850,0002.00%
EcoR1 Capital, LLC 2,634,178$36,878,0001.27%
RA Capital Management 2,186,636$30,613,0000.82%
Vivo Capital, LLC 476,589$6,672,0000.67%
Avoro Capital Advisors LLC 2,222,222$31,111,0000.62%
Artal Group S.A. 400,000$5,600,0000.30%
Rock Springs Capital Management LP 460,391$6,445,0000.19%
View complete list of DESIGN THERAPEUTICS INC shareholders